Marina Pointe Healthcare & Subacute | |
5240 Sepulveda Blvd, Culver City, California 90230 | |
(310) 391-7266 | |
Name | Marina Pointe Healthcare & Subacute |
---|---|
Location | 5240 Sepulveda Blvd, Culver City, California |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 116 |
Occupancy Rate | 73.45% |
Medicare ID (CCN) | 555340 |
Legal Business Name | Acsb Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1801201843 |
Organization Name | ACSB, LLC |
Doing Business As | MARINA POINTE SUBACUTE |
Address | 5240 Sepulveda Blvd, Culver City, CA 90230 |
Phone Number | 310-391-7266 |
News Archive
Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
The "humanized mouse" developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection.
A new survey, ordered by the University of Ottawa Heart Institute, shows that a majority of Canadian women lack knowledge of heart disease symptoms and risk factors, and that a significant proportion is even unaware of their own risk status.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
The "humanized mouse" developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection.
A new survey, ordered by the University of Ottawa Heart Institute, shows that a majority of Canadian women lack knowledge of heart disease symptoms and risk factors, and that a significant proportion is even unaware of their own risk status.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $18296 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.99 | 14.46 |
Percentage of long-stay residents who lose too much weight | 6.69 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 32.18 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.15 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.41 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.38 | 5.05 |
Percentage of long-stay residents who were physically restrained | 2.53 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.58 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.73 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 5.2 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.98 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 3.64 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.3 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.97 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 25 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.71 | 95.98 |
Percentage of short-stay residents who made improvements in function | 85.72 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.74 | 82.93 |
News Archive
Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix-) to reduce shunt-related blood flow issues is not effective in the dose studied.
The "humanized mouse" developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection.
A new survey, ordered by the University of Ottawa Heart Institute, shows that a majority of Canadian women lack knowledge of heart disease symptoms and risk factors, and that a significant proportion is even unaware of their own risk status.
› Verified 2 days ago
Marina Pointe Healthcare & Subacute Location: 5240 Sepulveda Blvd, Culver City, California 90230 Phone: (310) 391-7266 | |
Southern California Hosp At Culver City D/p Snf Location: 3828 Delmas Terrace, Culver City, California 90230 Phone: (323) 836-7000 |